tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market

Genmab (GMAB) Income Statement

Compare
614 Followers

Genmab Income Statement

Last quarter (Q4 2024), Genmab's total revenue was kr6.44B, an increase of 37.69% from the same quarter last year. In Q4, Genmab's net income was kr3.85B. See Genmab’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 21.53Bkr 16.47Bkr 14.60Bkr 8.48Bkr 10.11B
Gross Profit
kr 20.54Bkr 16.25Bkr 14.60Bkr 8.48Bkr 10.11B
Operating Expenses
kr 13.84Bkr 10.93Bkr 8.24Bkr 5.46Bkr 3.80B
Depreciation and Amortization
kr 413.00Mkr 240.00Mkr 290.00Mkr 250.00Mkr 246.00M
EBITDA
kr 7.39Bkr 5.56Bkr 7.04Bkr 3.15Bkr 6.54B
Operating Income
kr 6.70Bkr 5.32Bkr 6.36Bkr 3.02Bkr 6.31B
Other Income/Expenses
kr 2.46Bkr 316.00Mkr 768.00Mkr 965.00Mkr -409.00M
Pretax Income
kr 9.16Bkr 5.64Bkr 7.04Bkr 3.98Bkr 5.90B
Net Income
kr 7.84Bkr 4.35Bkr 5.45Bkr 2.96Bkr 4.76B
Per Share Metrics
Basic EPS
kr 121.36kr 66.02kr 8.34kr 4.52kr 7.30
Diluted EPS
kr 121.36kr 66.02kr 8.26kr 4.48kr 7.22
Weighted Average Shares Outstanding
64.63M 65.92M 653.87M 653.96M 651.79M
Weighted Average Shares Outstanding (Diluted)
64.63M 65.91M 660.10M 660.46M 658.86M
Currency in DKK

Genmab Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis